Can-Fite BioPharma Ltd. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2016 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Can-Fite BioPharma Ltd. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2016 to Q2 2022.
  • Can-Fite BioPharma Ltd. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 30, 2022 was $9.89M, a 150% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $9.89M +$5.94M +150% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $14.4M +$8.31M +137% Dec 31, 2021 6-K 2022-08-25
Q2 2021 $3.96M -$5.2M -56.8% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $6.07M +$3.63M +149% Dec 31, 2020 6-K 2021-08-26
Q2 2020 $9.16M +$715K +8.47% Jun 30, 2020 6-K 2021-08-26
Q4 2019 $2.44M -$573K -19% Dec 31, 2019 6-K 2021-08-26
Q2 2019 $8.44M Jun 30, 2019 6-K 2020-08-27
Q4 2018 $3.02M +$31K +1.04% Dec 31, 2018 6-K 2020-08-27
Q4 2017 $2.98M -$923K -23.6% Dec 31, 2017 6-K 2020-06-01
Q4 2016 $3.91M Dec 31, 2016 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.